Journal Article DZNE-2021-00192

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis.

 ;  ;  ;  ;  ;  ;

2020
Frontiers Media Lausanne

Frontiers in Bioengineering and Biotechnology 8, 586890 () [10.3389/fbioe.2020.586890]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The real-time quaking-induced conversion (RT-QuIC) assay is a highly reproducible and robust methodology exhibiting an excellent pre-mortem diagnostic accuracy for prion diseases. However, the protocols might be time-consuming and improvement of the detection technology is needed. In the present study, we investigated the influence of a pre-analytical cerebrospinal fluid (CSF) treatment with proteinase K (PK) on the kinetic of the RT-QuIC signal response. For this purpose, we added PK at different concentrations in RT-QuIC reactions seeded with Creutzfeldt-Jakob disease (sCJD) CSF. We observed that a mild pre-analytical PK treatment of CSF samples resulted in an increased seeding efficiency of the RT-QuIC reaction. Quantitative seeding parameters, such as a higher area under the curve (AUC) value or a shorter lag phase indicated a higher conversion efficiency after treatment. The diagnostic accuracy resulting from 2 μg/ml PK treatment was analyzed in a retrospective study, where we obtained a sensitivity of 89%. Additionally, we analyzed the agreement with the previously established standard RT-QuIC protocol without PK treatment in a prospective study. Here, we found an overall agreement of 94% to 96%. A Cohen's kappa of 0.9036 (95% CI: 0.8114-0.9958) indicates an almost perfect agreement between both protocols. In conclusion, the outcome of our study can be used for a further optimization of the RT-QuIC assay in particular for a reduction of the testing time.

Keyword(s): Creutzfeldt-Jakob disease ; cerebrospinal fluid ; diagnostic test ; prion protein ; real-time quaking-induced conversion

Classification:

Note: ISSN 2296-4185 not unique: **3 hits**.

Contributing Institute(s):
  1. Translational Studies and Biomarkers (AG Zerr)
  2. Ext UMG Zerr (Ext UMG Zerr)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2020
Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; OpenAccess ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-Ext UMG Zerr
Institute Collections > GÖ DZNE > GÖ DZNE-AG Zerr
Full Text Collection
Public records
Publications Database

 Record created 2021-03-31, last modified 2023-09-15